Mediating effect of acarbose on neurotransmitters in mental disorders: a review  

作　　者：Huasu Liang 

机构地区：[1]Department of Endocrinology and Metabolism,The First People's Hospital of Zhaotong/Zhaotong Hospital Affiliated to Kunming Medical University,Zhaotong 657000,China

出　　处：《Journal of Translational Neuroscience》2023年第3期14-19,共6页转化神经科学电子杂志（英文）

摘　　要：Acarbose is used to control postpran-dial blood glucose in patients with type 2 diabetes and impaired glucose tolerance,since it improves insulin resistance and reduces blood lipids and cardiovascular complications.However,in recent years,many studies have found that acarbose can mediate and regulate a variety of neurotransmitter-related diseases,although the mechanisms are not clear.Therefore,this paper analyzes the clinical effect of acarbose and its mediating effect on neurotransmitters of mental disorders through insulin,braingut axis,and calorie restriction,to provide a reference for the new clinical applications of acarbose.

关 键 词：ACARBOSE NEUROTRANSMITTER INSULIN brain-gut axis calorie restriction 

分 类 号：R749[医药卫生—神经病学与精神病学]